Indication
Systemic sclerosis associated interstitial lung disease
2 clinical trials
2 products
Product
GenSci048Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseStatus: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
A Randomized, Placebo-controlled, Single-blind, Dose Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BAY 2395840 After Single and Multiple Dose in Japanese Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2023-02-28
Product
Belimumab